Cornerstone Advisors (Washington)’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-65
Closed -$1K 759
2019
Q3
$1K Buy
+65
New +$936 ﹤0.01% 674
2017
Q3
Sell
-100
Closed -$2K 928
2017
Q2
$2K Hold
100
﹤0.01% 799
2017
Q1
$2K Hold
100
﹤0.01% 802
2016
Q4
$2K Hold
100
﹤0.01% 816
2016
Q3
$3K Sell
100
-100
-50% -$2.97K ﹤0.01% 745
2016
Q2
$5K Hold
200
0.01% 563
2016
Q1
$4K Hold
200
﹤0.01% 609
2015
Q4
$6K Buy
200
+50
+33% +$1.52K 0.01% 528
2015
Q3
$3K Buy
+150
New +$4.71K ﹤0.01% 655

Other funds holding MGNX

Cornerstone Advisors (Washington)'s MGNX Position: Q4 2019 in Review

Cornerstone Advisors (Washington) sold out of MacroGenics (MGNX) in Q4 2019, closing a stake of 65 shares — an estimated $1K sold.

Cornerstone Advisors (Washington) first reported a position in MGNX in Q3 2015 and held it in 9 quarters. The position peaked at $6K in Q4 2015. 124 funds tracked by Wall St. Rank hold MGNX as of Q4 2019.

  • Cornerstone Advisors (Washington) reported no remaining MacroGenics position as of Q4 2019 after selling out during the quarter.
  • Cornerstone Advisors (Washington) sold 65 MacroGenics shares in Q4 2019, an estimated $1K.
  • Cornerstone Advisors (Washington) first reported a position in MacroGenics in Q3 2015 and held it in 9 quarters.
  • Cornerstone Advisors (Washington)'s MacroGenics position peaked at $6K in Q4 2015.
  • 124 funds tracked by Wall St. Rank held MacroGenics as of Q4 2019.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q4 2019, filed 30 Jan 2020.